Abstract
In contrast to naive T cells, activated T cells are susceptible to TCR-induced cell death. This has been reported for antigenor anti-CD3 activated T cells of the CD4 + CD8" or CD4" CD8 + phenotype (1) (2) (3) (4) (5) . Interestingly, this form of TCR-induced apoptotic cell death is shown to be dependent on the expression of the Fas (CD95) antigen by activated T cells (2) (3) (4) (5) . The Fas antigen and its ligand are encoded by the Ipr and gld genes respectively (6) . Importantly, mice with homozygous mutations for the Ipr or gld gene developed an autoimmune syndrome similar to systemic lupus erythematosus (6) . Furthermore, the expression of Fas and its ligand is upregulated on activated T cells and TCR-induced cell death of activated cells can occur via an autocrine mechanism (7) (8) (9) leading to the proposal that the Fas signaling pathway is an important regulator of immune response in vivo (6, 10) . In support of this model is the recent observation that the peripheral deletion of CD4 cells by antigenic peptide was dependent on Fas expression by the activated CD4 cells (4) . The Fas signaling pathway is also required for the in vivo deletion of self-reactive B cells by CD4 T cells (11) . In this study we examine the requirement for Fas expression in the regulation of immune responses in vivo by CD8 cells expressing a male antigen-specific TCR.
CD4"CD8 + T cells expressing a transgenic TCR specific for the male antigen presented by D b class I MHC molecules are positively selected in female H-2 b H-Y TCR transgenic mice (12, 13) . CD4"CD8 + T cells expressing this transgenic TCR but lacking Fas expression were obtained by backcrossing the Ipr mutation from B6-lpr/lpr mice onto H-Y TCR transgenic mice. Positive and negative selection of the H-Y TCR occur normally in Ipr/lpr mutant mice (14, 15) . It has also been shown that the male-specific CD8 cells proliferate vigorously in the spleen and lymph nodes of male, but not female, B6-nu/nu mice (16) . This proliferation peaks at day 5 and declines rapidly thereafter. As this decline has been correlated with the appearance of apoptotic cells (17) , it is attractive to speculate that the elimination of the activated male-specific cells occurs by an activation-induced cell death On day 5 (A) and day 9 (B) two recipient mice from each group were killed and the frequency of male-specific cells in the lymph nodes (brachial, auxiliary inguinal, and mesenteric) of these mice was determined by three-color staining with FITC-labeled anti-CD8, phycoerythrin-labeled anti-CD4 and biotinylated T3.70 mAb followed by Streptavidin-TriColor. The T3.70 mAb is specific for the transgenic TCR a chain (12) . The stained cells were analyzed with the FACScan flow cytometer using Lysys II software. A total of 25,000 events were analyzed. It was previously shown that peripheral T cells with the CD8 + T3.70 + phenotype were specific for the male antigen (29, 30 mechanism involving the Fas signaling pathway. To evaluate this possibility we injected lymph node cells from female H-Y TCR and H-Y TCR/Ipr/lpr transgenic mice into B6-nu/nu male and female mice and determined the recovery of malespecific cells in the nu/nu recipients on day 5 and day 9. To determine whether the decline in the anti-male response is due to cell death, we included in these experiments lymph node cells from female H-Y TCR transgenic mice which constitutively expressed a transgenic Bcl-2 protein (18, 19) . It was previously shown that although the transgenic bcl-2 gene was under the control of the proximal Ick promoter, significant expression of the transgenic Bcl-2 protein was observed in peripheral T cells and expression of the transgenic Bcl-2 protein confers protection of T cells from death induced by various stimuli (19) . As shown in Fig but not female, nu/nu recipient mice on day 5, regardless of whether the inoculum came from female H-Y TCR, H-Y JCR/lpr/lpr or H-Y JCR/bcl-2 transgenic mice. As previously reported (16) , there was a dramatic decline on day 9 in the frequency of male-specific cells in the lymph nodes of male nu/nu recipients which received male-specific precursor cells from H-Y TCR transgenic mice (Fig. 1B) . This decline was prevented by the transgenic Bcl-2 protein, suggesting that it is due to a cell death mechanism which is inhibitable by Bcl-2. Surprisingly, this decline was also observed in male nu/nu recipients which received male-specific precursor cells from H-Y JCR/lpr/lpr transgenic mice. Since CD8 + T cells are known to give rise to B220 + CD4"CD8~ T cells in Ipr mutant mice (20) (21) (22) + into CD8~ cells. Rather these results indicate that the Fas signaling pathway is not essential for the elimination of activated male-specific cells between day 5 and day 9 of the response. Similar results were observed in the spleens of nu/nu recipient mice. A quantitation of the recovery of male-specific CD8 cells in the lymph nodes and spleens of male and female nu/nu recipient mice is shown in Fig. 2 . Male-specific cells from H-Y TCR transgenic mice proliferated slightly more efficiently than male-specific cells from H-Y JCR/lpr/lpr transgenic mice. This is consistent with a role for the Fas-signaling pathway in potentiating activation signals from the TCR signaling pathway (23) . The results also confirm a decline in the anti-male response between day 5 and day 9 that was inhibited by the transgenic Bcl-2 protein but not by the lack of Fas expression by male-specific cells.
The expression of Fas and TCR by male antigen-activated CD8 cells from H-Y, H-Y/lpr-lpr and H-Y/bcl-2 mice is shown in Fig. 3(A) . Male antigen-activated cells from all three types of mice expressed the same level of the transgenic TCR p chain. In contrast, only activated cells from H-Y and H-Y/bcl-2 but not H-Y/lpr-lpr mice expressed high levels of the Fas antigen (Fig. 3A) . We also determined whether the absence of Fas expression or the presence of the transgenic Bcl-2 protein in these cells protected them from TCR-induced cell death. As shown in Fig. 3(B) , male antigen-activated Fas + CD8 cells were highly susceptible to killing by immobilized anti-TCR antibody; Bcl-2 did not protect Fas + cells from TCR-induced cell death. This killing was TCR-specific since immobilized anti-Thy-1 antibody did not induce killing of these activated cells (data not shown and 24). By contrast, male antigen-activated Fas" CD8 cells were resistant to killing by anti-TCR antibody (Fig. 3B) . The lack of protection of Fas + cells from killing by stimulation with immobilized anti-TCR antibody appears to be at variance with the in vivo protection observed with the transgenic Bcl-2 protein. This discrepancy is likely due to the manner by which the male antigenactivated cells were stimulated. Stimulation with anti-TCR antibodies is independent of the affinity of the TCR for its physiological ligand or the density of the antigen-ligand present on antigen presenting cells. We propose that the transgenic Bcl-2 protein is sufficient to protect the male antigen-stimulated cells from a weak stimulus under physio- (4) . In that study, administration of PCC peptide into 2B4 TCR transgenic mice caused the peripheral deletion of PCC peptide-specific CD4 cells and this deletion was dependent on Fas expression by the PCC peptide-specific CD4 cells. There are several differences in that study that 1X10 6 ) from H-Y, H-Y/lpr-lpr or H-Ylbcl-2 mice were cultured with 1X10 7 irradiated (20 Gy) male B6 spleen cells in 2 ml of culture medium (Iscove's modified Dulbecco's medium supplemented with 5X10~5 M 2-mercaptoethanol and antibiotics) and 20 units of IL-2/ml. The cultures were split 1 in 4 on day 3 in IL-2 supplemented medium and male antigen-activated cells were analyzed for expression of Fas and TCR on day 5. This was done by three-color staining of activated cells with FITC-labeled anti-CD8, phycoerythrin-labeled anti-CD4 in combination with biotinylated anti-Fas (Jo-2) (31) or F23.1 mAb, which is specific for the transgenic TCR P chain (29) , and StreptavidinTriColor. The cells were analyzed with the FACScan flow cytometer using Lysys II software. A total of 10,000 events were analyzed. The male antigen-activated cells from all three types of mice were >95% CD4~CD8 + (data not shown). The histograms represent Fas and transgenic TCR p expression on gated CD4"CD8 + T cells. (B) Fas" cells are resistant to TCR-induced cell death. Day 5 male antigen-activated cells (1X10 5 ) cells were added to flat-bottomed microtiter wells that were not incubated or preincubated with 1 ng/ml of F23.1 mAb in PBS. The cells were incubated in antibody-coated wells with an excess of IL-2 (20 units/ml) in 0.2 ml of culture medium for 16 h at 37°C. The cells were then harvested and TCR-induced cell death was determined by staining with propidium iodide as previously described (5) . A total of 10,000 events were analyzed. The x-axis denotes propidium iodide fluorescence and the y-axis relative cell numbers. The numbers denote the proportion of dead cells in the M2 gate. The experiments were repeated three times with similar results. (C) Bcl-2 protects cell death resulting from IL-2 deprivation. Day 5 male antigen-activated cells were washed twice in PBS to remove residual IL-2 in the culture medium. They were then plated into flat-bottomed microtiter wells (1X10 5 cells/well; 0.2 ml/well) in medium alone or medium supplemented with 20 units of IL-2/ml. After 24 h incubation at 37°C the proportion of dead cells in these cultures was assessed as in (B). Percent specific killing was calculated using the formula: % specific killing = [(% subdiploid (-IL-2) -% subdiploid (+IL-2))/(100 -% subdiploid (+IL-2))]x 100. may account for the difference with regard to the importance of the Fas-signaling pathway in regulating immune responses in vivo: (i) the use of CD4 as opposed to CD8 cells, (ii) potential differences in the affinity of the TCR for their respective ligands, (iii) the administration of large doses of PCC peptide as opposed to a natural cell surface antigen and (iv) differences in the genetic background of the TCR transgenic mice, i.e. MRL-lpr/lpras opposed to B6-lpr/lpr. It is unlikely that the observed difference is due to the use of CD8 as opposed to CD4 cells since both CD4 and CD8 cells are susceptible to Fas-dependent TCR-stimulated cell death (2) . Further experiments are required to evaluate possibilities (ii) and (iii). With regard to the last possibility, it is important to note that the Ipr/ Ipr mutation is responsible for accelerating the autoimmune disease in MRL mice rather than inducing it (6, 25) .
This study also provides an explanation for Fas-independent regulation of the anti-male response by CD4~CD8 + T cells under in vivo conditions. Previous studies have shown that this particular male-specific response is dependent on CD4 T helper cells and the availability of IL-2 (17, 26) . As shown in Fig. 3(C) , male antigen-activated Fas" cells are highly susceptible to cell death following IL-2 deprivation. We propose that the rapid deletion of male antigen-activated Fas" cells in vivo is due to limiting amounts of IL-2 that are available in the microenvironment of the activated cells at the peak of the response. The observed increased survival of the activated male-specific cells in the presence of the transgenic Bcl-2 protein is consistent with our observation that this transgenic protein inhibited cell death resulting from IL-2 deprivation (Fig. 3C) . Another study also showed that overexpression of Bcl-2 can prolong the survival of IL-2-dependent T cells following IL-2 deprivation (27) .
A recent study investigated the relative contribution of the Fas and tumor necrosis factor (TNF) receptor signaling pathways in inducing the death of activated CD4 + and CD8 + cells after stimulation with immobilized anti-CD3e mAb (28) . The CD4 + and CD8 + cells were activated with concanavalin A for 48 h. It was found that whereas the death of most CD4 + T cells is Fas ligand mediated, the death of CD8 + T cells was primarily mediated by TNF. Our results are inconsistent with these conclusions since we found that cell death induced by stimulation of male antigen-activated CD8 + cells with immobilized anti-TCR antibodies was dependent on Fas expression (Fig. 3B ) and insensitive to killing by exogenous TNF (data not shown). The CD8 + cells used in our studies were activated with male antigen for 5 days. It remains to be determined whether the manner by which the CD8 + cells were activated contributed to the differences observed in these studies. However, regardless of these differences, the important conclusion is that in addition to Fas ligand-mediated killing, other distinct molecular mechanisms can contribute to the autoregulatory apoptosis of antigen-activated CD8 + cells.
